Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms Project PrEPare
- 08 Jun 2019 Results of pooled analysis of extension phase assessing Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men form this and NCT01772823 published in the Clinical Infectious Diseases
- 05 Sep 2017 Results published in the JAMA Pediatrics
- 24 Aug 2017 Results of this trial and another one (refer CTP: 700228444) assessing measures of adherence were published in the Clinical Infectious Diseases